Audiovestibular clinician experiences and opinions about cisplatin vestibulotoxicity

Pattarawadee Prayuenyong*, Anand V. Kasbekar, Deborah A. Hall, David M. Baguley

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Purpose: Vestibulotoxicity associated with cisplatin chemotherapy is known to exist, but the extent, severity, and impact is unclear from the literature. This study explored knowledge, experiences, and opinions of audiovestibular professionals about cisplatin vestibulotoxicity. Methods: An online survey was disseminated to clinicians working in the audiovestibular field. Results: Ninety-three respondents participated in the survey. Most professionals were aware of potential vestibulotoxicity associated with cisplatin chemotherapy. Thirty-three percent of the respondents reported that they had seen patients with cisplatin vestibulotoxicity. Forty percent of them were confident in making the diagnosis and in managing the patient in this situation. The prevalence and impact of vestibulotoxicity including practicality of the assessment should be considered when designing an effective vestibulotoxicity screening protocol. Conclusion: This study provides a better understanding of cisplatin vestibulotoxicity from the perspectives of audiovestibular clinicians, which will underpin appropriate detection and management of the condition.

Original languageEnglish
Pages (from-to)3283-3293
Number of pages11
JournalEuropean Archives of Oto-Rhino-Laryngology
Issue number12
Early online date19 May 2020
Publication statusPublished - 1 Dec 2020


  • Audiovestibular
  • Cisplatin
  • Vestibular
  • Vestibulotoxicity

ASJC Scopus subject areas

  • Otorhinolaryngology


Dive into the research topics of 'Audiovestibular clinician experiences and opinions about cisplatin vestibulotoxicity'. Together they form a unique fingerprint.

Cite this